Majority Of IHCs Deemed Class I, 510(k)-Exempt in June 3 Final Rule
This article was originally published in The Gray Sheet
Executive Summary
Low-risk immunohistochemical stains used as adjuncts to a conventional histopathologic diagnostic examination are classified as Class I and 510(k)-exempt by FDA's June 3 final rule on the in vitro devices.